Daniel M. Purdham

899 total citations
15 papers, 714 citations indexed

About

Daniel M. Purdham is a scholar working on Physiology, Endocrine and Autonomic Systems and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel M. Purdham has authored 15 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Endocrine and Autonomic Systems and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel M. Purdham's work include Adipose Tissue and Metabolism (7 papers), Regulation of Appetite and Obesity (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Daniel M. Purdham is often cited by papers focused on Adipose Tissue and Metabolism (7 papers), Regulation of Appetite and Obesity (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Daniel M. Purdham collaborates with scholars based in Canada. Daniel M. Purdham's co-authors include Venkatesh Rajapurohitam, Morris Karmazyn, Asad Zeidan, Sabzali Javadov, Min‐Xu Zou, Antonio Ciaccia, Morris Karmazyn, Lorrie A. Kirshenbaum, Sean P. Connors and Cathy Huang and has published in prestigious journals such as Circulation, PLoS ONE and The American Journal of Cardiology.

In The Last Decade

Daniel M. Purdham

15 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel M. Purdham Canada 11 332 269 261 229 137 15 714
Tomohiro Asahi Japan 9 212 0.6× 239 0.9× 131 0.5× 29 0.1× 56 0.4× 12 456
Reza Aghamohammadzadeh United Kingdom 11 443 1.3× 126 0.5× 230 0.9× 36 0.2× 66 0.5× 18 668
Lucia Salvemini Italy 16 213 0.6× 596 2.2× 337 1.3× 152 0.7× 133 1.0× 25 848
Mina Sonoda Japan 10 291 0.9× 398 1.5× 293 1.1× 56 0.2× 122 0.9× 11 679
P. Krespi Greece 10 245 0.7× 83 0.3× 58 0.2× 50 0.2× 42 0.3× 16 401
J.L. Amezcua Mexico 7 205 0.6× 29 0.1× 292 1.1× 49 0.2× 50 0.4× 11 482
A. Hatzizacharias Greece 10 216 0.7× 83 0.3× 59 0.2× 52 0.2× 41 0.3× 16 373
Ibrahim AlZaim Lebanon 13 114 0.3× 123 0.5× 123 0.5× 12 0.1× 96 0.7× 24 402
Necip Ermiş Türkiye 12 404 1.2× 49 0.2× 104 0.4× 17 0.1× 57 0.4× 48 614
Shintaro Minegishi Japan 15 205 0.6× 51 0.2× 66 0.3× 15 0.1× 134 1.0× 38 516

Countries citing papers authored by Daniel M. Purdham

Since Specialization
Citations

This map shows the geographic impact of Daniel M. Purdham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Purdham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Purdham more than expected).

Fields of papers citing papers by Daniel M. Purdham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Purdham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Purdham. The network helps show where Daniel M. Purdham may publish in the future.

Co-authorship network of co-authors of Daniel M. Purdham

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Purdham. A scholar is included among the top collaborators of Daniel M. Purdham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Purdham. Daniel M. Purdham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Turpie, Alexander G. G., Daniel M. Purdham, & Antonio Ciaccia. (2017). Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment. Therapeutic Advances in Cardiovascular Disease. 11(9). 243–256. 33 indexed citations
2.
Bell, Alan, Peter L. Gross, Michael Heffernan, et al.. (2016). Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation. The American Journal of Cardiology. 117(7). 1107–1111. 13 indexed citations
3.
Andrade, Jason G., Andrew D. Krahn, Allan C. Skanes, et al.. (2015). Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention. Canadian Journal of Cardiology. 32(6). 747–753. 89 indexed citations
4.
Andrade, Jadelson Pinheiro de, et al.. (2015). ATTITUDES, VALUES AND PREFERENCES OF PHYSICIANS AND PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION RECEIVING ORAL ANTICOAGULATION THERAPY FOR STROKE PREVENTION. Canadian Journal of Cardiology. 31(10). S303–S304. 1 indexed citations
5.
6.
Purdham, Daniel M., et al.. (2012). 179 Baseline Characteristics and In-Hospital Outcomes of TAVI in Ontario: Data From The Cardiac Care Network of Ontario (CCN) TAVI Registry. Canadian Journal of Cardiology. 28(5). S158–S158. 1 indexed citations
7.
Purdham, Daniel M., et al.. (2011). 216 Variation in classification and reporting of coronary anatomy: A provincial survey. Canadian Journal of Cardiology. 27(5). S138–S138. 4 indexed citations
8.
Purdham, Daniel M., Venkatesh Rajapurohitam, Asad Zeidan, et al.. (2008). A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart. American Journal of Physiology-Heart and Circulatory Physiology. 295(1). H441–H446. 49 indexed citations
9.
Karmazyn, Morris, Daniel M. Purdham, Venkatesh Rajapurohitam, & Asad Zeidan. (2008). Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovascular Research. 79(2). 279–286. 92 indexed citations
10.
Karmazyn, Morris, Daniel M. Purdham, Venkatesh Rajapurohitam, & Asad Zeidan. (2007). Leptin as a Cardiac Hypertrophic Factor: A Potential Target for Therapeutics. Trends in Cardiovascular Medicine. 17(6). 206–211. 56 indexed citations
11.
Rajapurohitam, Venkatesh, Sabzali Javadov, Daniel M. Purdham, & Morris Karmazyn. (2006). Abstract 542: Angiotensin II-Induced Leptin Secretion in Rat Neonatal Cardiomyocytes is Mediated by Two Different Mechanisms Involving JAk-STAT and NF-kB Activation. Circulation. 1 indexed citations
12.
Rajapurohitam, Venkatesh, Sabzali Javadov, Daniel M. Purdham, Lorrie A. Kirshenbaum, & Morris Karmazyn. (2006). An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. Journal of Molecular and Cellular Cardiology. 41(2). 265–274. 84 indexed citations
13.
Javadov, Sabzali, Daniel M. Purdham, Asad Zeidan, & Morris Karmazyn. (2006). NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 291(4). H1722–H1730. 36 indexed citations
14.
Zeidan, Asad, Daniel M. Purdham, Venkatesh Rajapurohitam, et al.. (2005). Leptin Induces Vascular Smooth Muscle Cell Hypertrophy through Angiotensin II- and Endothelin-1-Dependent Mechanisms and Mediates Stretch-Induced Hypertrophy. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1075–1084. 84 indexed citations
15.
Purdham, Daniel M., Min‐Xu Zou, Venkatesh Rajapurohitam, & Morris Karmazyn. (2004). Rat heart is a site of leptin production and action. American Journal of Physiology-Heart and Circulatory Physiology. 287(6). H2877–H2884. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohiro Asahi Breakdown of academic impact, for papers by Reza Aghamohammadzadeh Breakdown of academic impact, for papers by Lucia Salvemini Breakdown of academic impact, for papers by Mina Sonoda Breakdown of academic impact, for papers by P. Krespi Breakdown of academic impact, for papers by J.L. Amezcua Breakdown of academic impact, for papers by A. Hatzizacharias Breakdown of academic impact, for papers by Ibrahim AlZaim Breakdown of academic impact, for papers by Necip Ermiş Breakdown of academic impact, for papers by Shintaro Minegishi
Rankless by CCL
2026